Document is current
Any future updates will be listed below
-
Authors
Ziegler, Jörn F.
Böttcher, Chotima https://orcid.org/0000-0002-6226-586X
Letizia, Marilena
Yerinde, Cansu
Wu, Hao
Freise, Inka
Rodriguez-Sillke, Yasmina https://orcid.org/0000-0001-7572-380X
Stoyanova, Ani K.
Kreis, Martin E.
Asbach, Patrick
Kunkel, Desiree https://orcid.org/0000-0002-0054-955X
Priller, Josef
Anagnostopoulos, Ioannis
Kühl, Anja A.
Miehle, Konstanze
Stumvoll, Michael
Tran, Florian
Fredrich, Broder
Forster, Michael https://orcid.org/0000-0001-9927-5124
Franke, Andre https://orcid.org/0000-0003-1530-5811
Bojarski, Christian
Glauben, Rainer
Löscher, Britt-Sabina https://orcid.org/0000-0001-9022-9017
Siegmund, Britta https://orcid.org/0000-0002-0055-958X
Weidinger, Carl https://orcid.org/0000-0002-9948-0088
- License Information
-
More Information
Article History
Received: 9 July 2019
Accepted: 14 November 2019
First Online: 10 December 2019
Competing interests
: K.M. consulted for Aegerion Pharmaceuticals. B.S. has served as consultant for Abbvie, Boehringer, Celgene, Falk, Janssen, Lilly, Pfizer, Prometheus, Takeda and received speaker’s fees from Abbvie, CED Service GmbH, Falk, Ferring, Janssen, Novartis, Takeda (B.S. served as representative of the Charité). The remaining authors declare no competing interests.
